Login / Signup

Severe growth failure associated with a novel heterozygous nonsense mutation in the GHR transmembrane domain leading to elevated growth hormone binding protein.

Ankur RughaniDongsheng ZhangKanimozhi VairamaniAndrew DauberVivian HwaSowmya Krishnan
Published in: Clinical endocrinology (2020)
To our knowledge, this is the first study to demonstrate in vitro that elevated levels of GHBP attenuate the effect of GH and inhibit GH-induced signalling, thereby leading to short stature. Though this inhibition was overcome in vitro with supraphysiologic doses of GH, significantly above endogenously available GH, it remains to be seen whether such an effect can be replicated in vivo.
Keyphrases
  • growth hormone
  • binding protein
  • early onset
  • healthcare
  • diabetic rats
  • oxidative stress